FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pediatric surgery, and can be used for children with Hirschsprung's disease in perioperative period with antibacterial prevention. Preoperative preparation involves determination of carriers of toxigenic strains C.difficile, for this purpose, admission to the hospital is followed by examination of faeces for toxigenic strains C.difficile. If C.difficile toxins A and B (or A+B) are detected, an antibacterial therapy is prescribed: vancomycin 10 mg/kg for admission 4 times day for 7 days. Simultaneously, a probiotic preparation is administered based on Saccharomyces boulardii 250 mg once day for 7 days. In intraoperative period 60 minutes before the operation, metronidazole 7.5 mg/kg is intravenously administered. 30–40 minutes before the operation intravenous introduction of cefazolin 25 mg/kg. If the surgical intervention is continued for more than 3–4 hours, one more dose of cefazolin is added. Either 120 minutes before the surgical intervention, vancomycin 40 mg/kg is administered. That is followed by intravenous administration of cefazolin 25 mg/kg 30–40 minutes before the operation. If the surgical intervention is continued for more than 3–4 hours, one more dose of cefazolin is added. If observing allergic reactions to beta-lactam antibiotics, a combination of clindamycin 600 mg/kg and gentamycin 5 mg/kg is administered 40–60 minutes prior to surgery. In the presence of infectious complications in the postoperative period, etiotropic antibiotic and a probiotic based on S. boulardii 250 mg once day for 7 days are prescribed. If observing no infectious complications, the antibacterial therapy is not followed, and the S. boulardii-based probiotic is prescribed for 7 days.
EFFECT: invention enables reducing a risk of enterocolitis and other infectious complications and reduces length of stay of the patient in a hospital bed.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING NUTRITIONAL INSUFFICIENCY IN CHILDREN SUFFERING HIRSCHSPRUNG DISEASE | 2018 |
|
RU2694839C1 |
METHOD OF PREVENTION OF POSTOPERATIVE SUPPURATIVE AND SEPTIC COMPLICATIONS IN CARDIOSURGERY | 2007 |
|
RU2350329C1 |
METHOD FOR PREVENTING AND TREATING INFECTIOUS PROCESSES ACCOMPANYING DENTAL SURGERIES | 2013 |
|
RU2531941C1 |
METHOD OF PERIOPERATIVE PREPARATION OF PATIENTS | 2015 |
|
RU2580650C1 |
METHOD FOR INTEGRATED TREATMENT OF NECROTISING ENTEROCOLITIS IN NEWBORNS AND INFANTS | 2013 |
|
RU2527348C1 |
METHOD OF COMPLEX THERAPY IN EARLY AGE CHILDREN WITH CYTOMEGALOVIRUS AND LOCOMOTOR SYSTEM PATHOLOGY IN CASE OF PLANNED SURGERY | 2009 |
|
RU2400234C1 |
METHOD FOR PREVENTION OF POSTOPERATIVE INFECTIOUS COMPLICATIONS IN NEUROSURGICAL PATIENTS IN CHRONIC CRITICAL CONDITION CAUSED BY BRAIN INJURY | 2023 |
|
RU2817214C1 |
METHOD FOR PREVENTING RESPIRATORY COMPLICATIONS IN PATIENTS AFTER ACCOMPANY VARTILE SURGICAL TREATMENT OF LUNG CANCER | 2018 |
|
RU2684761C1 |
METHOD FOR PREVENTING POSTOPERATIVE PYOINFLAMMATORY COMPLICATIONS | 2005 |
|
RU2286167C2 |
METHOD OF PREVENTING INFECTIOUS AND INFLAMMATORY COMPLICATIONS IN WOMEN WITH SUBMUCOSAL UTERINE MYOMA AFTER HYSTERORESECTOSCOPY | 2013 |
|
RU2565444C2 |
Authors
Dates
2019-07-16—Published
2018-08-16—Filed